You are here Home › About
First Warning Systems, Inc. is licensed by its parent company, Lifeline Biotechnologies. The license grants First Warning Systems, Inc. all rights, worldwide, for further product development, regulatory, manufacturing and marketing.
First Warning System™(FWS) is a novel breast health screening device and method based on disruptive technology and tissue health science. The system is a non-invasive breast physiology screening system, much more sensitive and much more cost effective than mammography. The platform has applications for both OB/GYN and primary care in-office use, as well as potential use as an over-the-counter (OTC) diagnostic system.
Funding Rounds (6) - $5.89MUpdate
Current Team (4)Update
|Jun 2, 2016||PRWeb Sitemap - Cyrcadia Health Expands Advisory Board with Nationally Recognized Author and Sports Business Advisor Mandy Antoniacci|
|Apr 27, 2016||PRWeb Sitemap - Cyrcadia Health Takes Home Gold 2016 Edison Award for Top Health and Wellness Wearable|
|Apr 5, 2016||PRWeb Sitemap - Cyrcadia Health Expands Breast Cancer Screening Trial to The Ohio State University|
|Apr 1, 2016||Market Wired - Top - Lifeline Biotechnologies Announces a Cyrcadia Milestone and 2016 Expectations|
|Dec 23, 2015||Market Wired - Top - Lifeline Biotechnologies Summarizes 2015, Looks Forward to 2016|
|Dec 7, 2015||SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION|
|Aug 11, 2015||PRWeb Sitemap - Cyrcadia, Inc. Announces ClinicalTrials.gov Listing for Its Entry into Clinical Trials for Wearable Breast Cancer Detection Device|
|Jul 7, 2015||PRWeb Sitemap - Cyrcadia, Inc. Enters Clinical Trials for Wearable Breast Cancer Detection Device|
1325 Airmotive Way, Ste 175-L
Reno, NV 89502